ART: Anal Squamous Cell Carcinoma: Investigation of Functional Imaging During chemoRadioTherapy

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

29 participants

Study Classification

OBSERVATIONAL

Study Start Date

2015-01-27

Study Completion Date

2018-04-12

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This is a single arm, single centre imaging study which will be offered to all consecutive, eligible patients receiving radical chemoradiation therapy (CRT) for anal cancer within Oxford University Hospitals.

Investigations

* Dynamic contrast enhanced magnetic resonance imaging (DCE MRI)
* Diffusion weighted magnetic resonance imaging (DWI MRI)
* MRI scan designed to measure the T1 or produce T1-weighed images (T1 MRI)
* MRI scan designed to measure the T2\* or produce T2\*-weighed images (T2\* MRI)
* Perfusion computed tomography (pCT)
* Fludeoxyglucose positron emission tomography (FDG PET/CT)

Study Design: Observational

Target Population: Patients undergoing radical CRT for anal cancer in Oxford University Hospitals National Health Service (NHS) Trust.

Duration on study: Patients should be on study for a maximum of 5 months.

Patient care post-trial: Follow up as per local standard.

No. of Study Site(s): Single Centre, United Kingdon (UK)

End of study: Last Patient, last assessment of response. Patients should be on study for a maximum of 5 months.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

MRI for Selection of Complete Responders After Chemoradiation for Locally Advanced Rectal Cancer

NCT04790227

Cancer, Rectum

UNKNOWN

Prediction of Response to Neoadjuvant Therapy in Rectal Cancer

NCT02439086

Rectal Neoplasms

UNKNOWN NA

Evaluation of Rectal Cancer Treatment Response Using PET/MRI

NCT02233595

Rectal Adenocarcinoma

TERMINATED

Optimisation of Radiotherapy in Rectal Cancer (ORREC)

NCT04090450

Rectal Adenocarcinoma

UNKNOWN

Radioisotope and Fluorescence Guidance in Rectal Cancer

NCT05336643

Rectal Cancer Lymph Node Metastasis

UNKNOWN NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Anal Cancer

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Histologically confirmed invasive primary squamous carcinoma of the anus.
* Patients must be fit and scheduled to receive radical CRT with curative intent.
* Any stage tumor 2-node 0 (T2N0)
* Male or female, Age 18 years+.
* The patient is willing and able to comply with the images and protocol for the duration of the study.
* Written (signed and dated) informed consent.

Exclusion Criteria

* Pregnant or breast-feeding women or women of childbearing potential unless effective methods of contraception are used.
* Previous pelvic radiotherapy
* Patients with a pacemaker or any other implanted metal which would preclude MRI scan.
* Patients with a prosthetic hip.
* Patients receiving radiotherapy with palliative intent.
* Active medical or psychological illness that would render the patient unsuitable for the additional imaging proposed in this study, at the discretion of the investigator

Additional criteria for optional oxygen breathing procedure:

* Patients with Chronic Obstructive Pulmonary Disease
* Any patient not felt to be suitable for supplementary oxygen as considered by an appropriately trained clinician

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No